Myth or Medicine?: Is a new GLP-1 drug safe for consumers?

As GLP-1s become increasingly more common, a new generation of these drugs has hit some markets without FDA approval. One of them is called Retatrutide — already popular on the online peptide gray market, but achieving higher rates of weight loss. Internal medicine resident and Medical Mythbuster, Dr. Joel Bervell, breaks down the science behind GLP-1s and provides a warning about unmarked vials of Retatrutide being sold to consumers.

MS NOW: My Source for News, Opinion, and the World.

» Subscribe to MS NOW: https://www.youtube.com/@msnow

» Become an MS NOW Member! Join us here http://ms.now/membership

MS NOW is the go-to destination for domestic and international breaking news, and best-in-class opinion journalism. For more context and news coverage of the most important stories of our day click here: https://www.ms.now/